Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT00003420
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed nonseminomatous germ cell tumor of the testis Stage I disease:
* No evidence of metastatic disease on clinical examination
* Normal chest x-ray
* Normal chest and abdominal CT scan
* Normal serum tumor marker (AFP, HCG) after orchidectomy
* High risk patients should be considered for ongoing studies of adjuvant chemotherapy after orchidectomy, but those choosing not to take this option may enter this study
* Orchidectomy no greater than 8 weeks prior to randomization into this study
PATIENT CHARACTERISTICS:
Age:
* Not specified
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* No other concurrent or prior malignancy except successfully treated nonmelanomatous skin cancer
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* Not specified
Endocrine therapy:
* Not specified
Radiotherapy:
* Not specified
Surgery:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT00003420
Study Brief:
Protocol Section:
NCT00003420